|
1
|
Bielack SS, Kempf-Bielack B, Delling G, et
al: Prognostic factors in high-grade osteosarcoma of the
extremities or trunk: an analysis of 1,702 patients treated on
neoadjuvant cooperative osteosarcoma study group protocols. J Clin
Oncol. 20:776–790. 2002. View Article : Google Scholar
|
|
2
|
Marina N, Gebhardt M, Teot L and Gorlick
R: Biology and therapeutic advances for pediatric osteosarcoma.
Oncologist. 9:422–441. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bushati N and Cohen SM: microRNA
functions. Annu Rev Cell Dev Biol. 23:175–205. 2007. View Article : Google Scholar
|
|
5
|
Griffiths-Jones S: miRBase: the microRNA
sequence database. Methods Mol Biol. 342:129–138. 2006.PubMed/NCBI
|
|
6
|
Hwang HW and Mendell JT: MicroRNAs in cell
proliferation, cell death, and tumorigenesis. Br J Cancer.
94:776–780. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yan K, Gao J, Yang T, et al: MicroRNA-34a
inhibits the proliferation and metastasis of osteosarcoma cells
both in vitro and in vivo. PloS One. 7:e337782012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kumar MS, Lu J, Mercer KL, Golub TR and
Jacks T: Impaired microRNA processing enhances cellular
transformation and tumorigenesis. Nat Genet. 39:673–677. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang B, Pan X, Cobb GP and Anderson TA:
microRNAs as oncogenes and tumor suppressors. Dev Biol. 302:1–12.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kobayashi E, Hornicek FJ and Duan Z:
MicroRNA involvement in osteosarcoma. Sarcoma. 2012:359732012.
View Article : Google Scholar
|
|
12
|
Zhang H, Cai X, Wang Y, Tang H, Tong D and
Ji F: microRNA-143, down-regulated in osteosarcoma, promotes
apoptosis and suppresses tumorigenicity by targeting Bcl-2. Oncol
Rep. 24:1363–1369. 2010.PubMed/NCBI
|
|
13
|
Ji F, Zhang H, Wang Y, et al:
MicroRNA-133a, downregulated in osteosarcoma, suppresses
proliferation and promotes apoptosis by targeting Bcl-xL and Mcl-1.
Bone. 56:220–226. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jin Y, Peng D, Shen Y, et al:
MicroRNA-376c inhibits cell proliferation and invasion in
osteosarcoma by targeting to transforming growth factor-alpha. DNA
Cell Biol. 32:302–309. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Namlos HM, Meza-Zepeda LA, Baroy T, et al:
Modulation of the osteosarcoma expression phenotype by microRNAs.
PloS One. 7:e480862012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sureban SM, May R, Mondalek FG, et al:
Nanoparticle-based delivery of siDCAMKL-1 increases microRNA-144
and inhibits colorectal cancer tumor growth via a Notch-1 dependent
mechanism. J Nanobiotechnology. 9:402011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT Method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Diaz-Prado S, Cicione C, Muinos-Lopez E,
et al: Characterization of microRNA expression profiles in normal
and osteoarthritic human chondrocytes. BMC Musculoskelet Disord.
13:1442012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Guo YS, Zhao R, Ma J, et al: βig-h3
promotes human osteosarcoma cells metastasis by interacting with
integrin α2β1 and activating PI3K signaling pathway. PloS One.
9:e902202014.
|
|
20
|
Lin CH, Guo Y, Ghaffar S, et al: Dkk-3, a
secreted wnt antagonist, suppresses tumorigenic potential and
pulmonary metastasis in osteosarcoma. Sarcoma.
2013:1475412013.PubMed/NCBI
|
|
21
|
Duan Z, Choy E, Harmon D, et al:
MicroRNA-199a-3p is downregulated in human osteosarcoma and
regulates cell proliferation and migration. Mol Cancer Ther.
10:1337–1345. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fan L, Wu Q, Xing X, Wei Y and Shao Z:
MicroRNA-145 targets vascular endothelial growth factor and
inhibits invasion and metastasis of osteosarcoma cells. Acta
Biochim Biophys Sin. 44:407–414. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bao YP, Yi Y, Peng LL, et al: Roles of
microRNA-206 in osteosarcoma pathogenesis and progression. Asian
Pac J Cancer Prev. 14:3751–3755. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jin J, Cai L, Liu ZM and Zhou XS:
miRNA-218 inhibits osteosarcoma cell migration and invasion by
down-regulating of TIAM1, MMP2 and MMP9. Asian Pac J Cancer Prev.
14:3681–3684. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yang Z, Chang YJ, Miyamoto H, et al:
Transgelin functions as a suppressor via inhibition of
ARA54-enhanced androgen receptor transactivation and prostate
cancer cell growth. Mol Endocrinol. 21:343–358. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lee EK, Han GY, Park HW, Song YJ and Kim
CW: Transgelin promotes migration and invasion of cancer stem
cells. J Proteome Res. 9:5108–5117. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Thompson O, Moghraby JS, Ayscough KR and
Winder SJ: Depletion of the actin bundling protein SM22/transgelin
increases actin dynamics and enhances the tumourigenic phenotypes
of cells. BMC Cell Biol. 13:12012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Assinder SJ, Stanton JA and Prasad PD:
Transgelin: an actin-binding protein and tumour suppressor. Int J
Biochem Cell Biol. 41:482–486. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li Q, Shi R, Wang Y and Niu X: TAGLN
suppresses proliferation and invasion, and induces apoptosis of
colorectal carcinoma cells. Tumour Biol. 34:505–513. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chunhua L, Donglan L, Xiuqiong F, et al:
Apigenin up-regulates transgelin and inhibits invasion and
migration of colorectal cancer through decreased phosphorylation of
AKT. J Nutr Biochem. 24:1766–1775. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lin Y, Buckhaults PJ, Lee JR, et al:
Association of the actin-binding protein transgelin with lymph node
metastasis in human colorectal cancer. Neoplasia. 11:864–873.
2009.PubMed/NCBI
|
|
32
|
Shi YY, Wang HC, Yin YH, et al:
Identification and analysis of tumour-associated antigens in
hepatocellular carcinoma. Br J Cancer. 92:929–934. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Li N, Zhang J, Liang Y, et al: A
controversial tumor marker: is SM22 a proper biomarker for gastric
cancer cells? J Proteome Res. 6:3304–3312. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Huang Q, Huang Q, Chen W, et al:
Identification of transgelin as a potential novel biomarker for
gastric adenocarcinoma based on proteomics technology. J Cancer Res
Clin Oncol. 134:1219–1227. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Mikuriya K, Kuramitsu Y, Ryozawa S, et al:
Expression of glycolytic enzymes is increased in pancreatic
cancerous tissues as evidenced by proteomic profiling by
two-dimensional electrophoresis and liquid chromatography-mass
spectrometry/mass spectrometry. Int J Oncol. 30:849–855. 2007.
|
|
36
|
Yu H, Konigshoff M, Jayachandran A, et al:
Transgelin is a direct target of TGF-beta/Smad3-dependent
epithelial cell migration in lung fibrosis. FASEB J. 22:1778–1789.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yu B, Chen X, Li J, et al: Stromal
fibroblasts in the microenvironment of gastric carcinomas promote
tumor metastasis via upregulating TAGLN expression. BMC Cell Biol.
14:172013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang H, Zhu Y, Zhao M, et al: miRNA-29c
suppresses lung cancer cell adhesion to extracellular matrix and
metastasis by targeting integrin β1 and matrix metalloproteinase2
(MMP2). PloS One. 8:e701922013.PubMed/NCBI
|
|
39
|
Wang XX, Cheng Q, Zhang SN, et al:
PAK5-Egr1-MMP2 signaling controls the migration and invasion in
breast cancer cell. Tumour Biol. 34:2721–2729. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yu G, Li H, Wang X, et al: MicroRNA-19a
targets tissue factor to inhibit colon cancer cells migration and
invasion. Mol Cell Biochem. 380:239–247. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Akiyoshi S, Fukagawa T, Ueo H, et al:
Clinical significance of miR-144-ZFX axis in disseminated tumour
cells in bone marrow in gastric cancer cases. Br J Cancer.
107:1345–1353. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zha W, Cao L, Shen Y and Huang M: Roles of
Mir-144-ZFX pathway in growth regulation of non-small-cell lung
cancer. PloS One. 8:e741752013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Guo Y, Ying L, Tian Y, et al: miR-144
downregulation increases bladder cancer cell proliferation by
targeting EZH2 and regulating Wnt signaling. FEBS J. 280:4531–4538.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zhang LY, Ho-Fun Lee V, Wong AM, et al:
MicroRNA-144 promotes cell proliferation, migration and invasion in
nasopharyngeal carcinoma through repression of PTEN.
Carcinogenesis. 34:454–463. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Selbach M, Schwanhausser B, Thierfelder N,
Fang Z, Khanin R and Rajewsky N: Widespread changes in protein
synthesis induced by microRNAs. Nature. 455:58–63. 2008. View Article : Google Scholar : PubMed/NCBI
|
